those living with neuromuscular diseases’
International Conference December 2022
TREAT-NMD is a network for the neuromuscular field that provides an infrastructure to ensure that the most promising new therapies reach patients as quickly as possible. Since its launch in January 2007 the network’s focus has been on the development of tools that industry, clinicians and scientists need to bring novel therapeutic approaches through preclinical development and into the clinic, and on establishing best-practice care for neuromuscular patients worldwide.
what we do
At TREAT-NMD we provide an infrastructure that is accelerating research and therapy development. With some of our initiatives, such as running disease specific masterclasses and providing aggregated and deidentified data reports in a secure fashion, we are increasing collaboration, improving patient care and helping to support ‘clinical trial readiness’ on an international scale.
Our network consists of world experts in neuromuscular field. We work and collaborate with patient groups, clinicians, researchers, and the pharmaceutical industry to connect and unite stakeholders in the neuromuscular community.
resources & support
We have a wealth of resources for patients, clinicians and industry. TREAT-NMD gives patient registries the opportunity to apply to become a TGDOC Member Registry and become part of the TREAT-NMD Global Registry Network. We also provide resources and information on the latest standards of care and have fantastic opportunities to engage with TREAT-NMD.